Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Vascular Therapies Stock

Q: How to sell Vascular Therapies stock?

If you hold private company shares of Vascular Therapies - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Vascular Therapies stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

vasculartx.comHealthcare / BioTech & PharmaFounded: 2001Funding to Date: $74.51MM

Vascular Therapies is a late-stage biopharmaceutical company focused on developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.

Buy or sell Vascular Therapies stockLearn more about Vascular Therapies IPO

OverviewFinancingsValuation

Enterprise Value

Access Vascular Therapies’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vascular Therapies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

John McDermott

Chief Executive Officer & Board Member

Paul Barkofsky Ph.D

Vice President, New Product Development

Maureen Harrison

Vice President, Quality Assurance

Sriram Iyer MD

Founder, Chief Scientific Officer & Board Member

Rosanne Terraciano

Vice President, Operations

Board Members

Andrew Midler

Savitr Capital

Kiyoshi Takesue

Robert Flanagan

Dan Ryan

Gerald Dorros MD

The Gerrald Dorros and Myra S. Dorros Recovable Trust

Robert Croce

New Enterprise Associates

Sriram Iyer MD

Allan Tessler

John McDermott

Michael Bamberger

Somasundaram Subramaniam

New Science Ventures

Vascular Therapies stock FAQs

Can you buy Vascular Therapies stock?

As Vascular Therapies is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Vascular Therapies, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Vascular Therapies stock?

To invest in a private company like Vascular Therapies through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Vascular Therapies stock?

Yes, you may be able to sell your Vascular Therapies stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Vascular Therapies stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Vascular Therapies stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Vascular Therapies a public company?

No, Vascular Therapies is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Vascular Therapies’ stock price?

Vascular Therapies is a privately held company and therefore does not have a public stock price. However, you may access Vascular Therapies’ private market stock price with Forge Data.

What is Vascular Therapies’ stock ticker symbol?

Vascular Therapies does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

PR Newswire 09/09/2019

Vascular Therapies Announces Positive Preliminary Clinical Results from its AV Fistula Trials in Patients with Kidney Disease

/PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogen™, a proprietary sirolimus formulation for intraoperative...

Mass Device 10/15/2018

Vascular Therapies raises $12m for drug-eluting vascular access implant

Vascular Therapies has raised $12.4 million from 29 investors as part of a $21.1 million round, according to a document filed last week with the SEC. The Cresskill, N.J.-based company is developing a sirolimus-eluting collagen implant for patients with end-stage renal disease. The bioresorbable drug-delivery system is designed to keep open a portal of entry […]

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.